Breaking News

Boehringer Invests $217M to Expand Fremont Mfg. Facility

To increase manufacturing capacity by one-third

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Boehringer Ingelheim is investing $217 million to upgrade and expand its Fremont, CA manufacturing facility. This investment will add nearly 300 skilled positions in the area. The site was recently awarded $25.5 million in two separate tax credits from the state, making them the largest award to a pharmaceutical company. The expansion will allow the company to increase its manufacturing capacity by one-third.   “The Bay Area is the largest biotech cluster in the world. We are happy to ha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters